134 related articles for article (PubMed ID: 10049447)
1. Impact of family history on screening and surveillance.
Burt RW
Gastrointest Endosc; 1999 Mar; 49(3 Pt 2):S41-4. PubMed ID: 10049447
[No Abstract] [Full Text] [Related]
2. Establishing a clinical and molecular diagnosis for hereditary colorectal cancer syndromes: Present tense, future perfect?
Jansen M; Menko FH; Brosens LA; Giardiello FM; Offerhaus GJ
Gastrointest Endosc; 2014 Dec; 80(6):1145-55. PubMed ID: 25434663
[No Abstract] [Full Text] [Related]
3. Screening families with endometrial and colorectal cancers for germline mutations.
Liu T; Chen J; Salahshor S; Kuismanen S; Holmberg E; Grönberg H; Peltomäki P; Lindblom A
J Med Genet; 2001 Sep; 38(9):E29. PubMed ID: 11546830
[No Abstract] [Full Text] [Related]
4. Identifying hereditary nonpolyposis colorectal cancer.
Lynch HT; Smyrk TC
N Engl J Med; 1998 May; 338(21):1537-8. PubMed ID: 9593794
[No Abstract] [Full Text] [Related]
5. A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening.
Yuan ZQ; Wong N; Foulkes WD; Alpert L; Manganaro F; Andreutti-Zaugg C; Iggo R; Anthony K; Hsieh E; Redston M; Pinsky L; Trifiro M; Gordon PH; Lasko D
J Med Genet; 1999 Oct; 36(10):790-3. PubMed ID: 10528862
[No Abstract] [Full Text] [Related]
6. HNPCC: an uncommon but important diagnosis.
Terdiman JP
Gastroenterology; 2001 Oct; 121(4):1005-8. PubMed ID: 11606514
[No Abstract] [Full Text] [Related]
7. Hereditary and somatic DNA mismatch repair gene mutations in sporadic endometrial carcinoma.
Chadwick RB; Pyatt RE; Niemann TH; Richards SK; Johnson CK; Stevens MW; Meek JE; Hampel H; Prior TW; de la Chapelle A
J Med Genet; 2001 Jul; 38(7):461-6. PubMed ID: 11474654
[No Abstract] [Full Text] [Related]
8. I1307K APC and hMLH1 mutations in a non-Jewish family with hereditary non-polyposis colorectal cancer.
Yuan ZQ; Kasprzak L; Gordon PH; Pinsky L; Foulkes WD
Clin Genet; 1998 Oct; 54(4):368-70. PubMed ID: 9831355
[TBL] [Abstract][Full Text] [Related]
9. Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation.
Wagner A; Tops C; Wijnen JT; Zwinderman K; van der Meer C; Kets M; Niermeijer MF; Klijn JG; Tibben A; Vasen HF; Meijers-Heijboer H
J Med Genet; 2002 Nov; 39(11):833-7. PubMed ID: 12414824
[No Abstract] [Full Text] [Related]
10. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A
N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786
[TBL] [Abstract][Full Text] [Related]
11. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.
Pucciarelli S; Agostini M; Viel A; Bertorelle R; Russo V; Toppan P; Lise M
Dis Colon Rectum; 2003 Mar; 46(3):305-12. PubMed ID: 12626904
[TBL] [Abstract][Full Text] [Related]
12. [Hereditary nonpolyposis colorectal cancer].
Matsukawa M; Yamamoto T; Kouda T
Nihon Rinsho; 2003 Sep; 61 Suppl 7():189-92. PubMed ID: 14574879
[No Abstract] [Full Text] [Related]
13. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of genetic testing of hereditary nonpolyposis colorectal cancer.
Vasen HF; Wijnen J
Cytogenet Cell Genet; 1999; 86(2):136-9. PubMed ID: 10545704
[No Abstract] [Full Text] [Related]
15. Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States.
Kurzawski G; Suchy J; Kładny J; Safranow K; Jakubowska A; Elsakov P; Kucinskas V; Gardovski J; Irmejs A; Sibul H; Huzarski T; Byrski T; Debniak T; Cybulski C; Gronwald J; Oszurek O; Clark J; Góźdź S; Niepsuj S; Słomski R; Pławski A; Łacka-Wojciechowska A; Rozmiarek A; Fiszer-Maliszewska Ł; Bebenek M; Sorokin D; Stawicka M; Godlewski D; Richter P; Brozek I; Wysocka B; Jawień A; Banaszkiewicz Z; Kowalczyk J; Czudowska D; Goretzki PE; Moeslein G; Lubiński J
J Med Genet; 2002 Oct; 39(10):E65. PubMed ID: 12362047
[No Abstract] [Full Text] [Related]
16. [Combining clinical investigation with molecular genetics research: to push forward the study of hereditary colorectal carcinoma into a higher level in China].
Li S
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1369-70. PubMed ID: 12613476
[No Abstract] [Full Text] [Related]
17. DNA repair comes into its own.
Marx J
Science; 1994 Nov; 266(5186):728-30. PubMed ID: 7973626
[No Abstract] [Full Text] [Related]
18. [EPICOLON project: contribution to the knowledge of Lynch syndrome and other familial or hereditary colorectal cancer].
Castells A; Andreu M;
Med Clin (Barc); 2007 Jan; 128(2):55-60. PubMed ID: 17266903
[No Abstract] [Full Text] [Related]
19. A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome.
Mangold E; Pagenstecher C; Leister M; Mathiak M; Rütten A; Friedl W; Propping P; Ruzicka T; Kruse R
J Med Genet; 2004 Jul; 41(7):567-72. PubMed ID: 15235030
[No Abstract] [Full Text] [Related]
20. Molecular basis of HNPCC: mutations of MMR genes.
Papadopoulos N; Lindblom A
Hum Mutat; 1997; 10(2):89-99. PubMed ID: 9259192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
